These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36742578)

  • 21. Patulous Eustachian Tube Patients With Respiratory Fluctuation of Tympanic Membrane in Both Sitting and Supine Positions: A Sign of Severity of Disease?
    Kusano Y; Kawamura Y; Ikeda R; Oshima H; Kikuchi T; Kawase T; Katori Y; Kobayashi T
    Otol Neurotol; 2021 Sep; 42(8):e1058-e1061. PubMed ID: 33989255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plug size selection protocol for the treatment of intractable patulous Eustachian tube with Kobayashi Plug.
    Ikeda R; Kikuchi T; Kawamura Y; Miyaaki H; Kawase T; Katori Y; Kobayashi T
    Acta Otolaryngol; 2019 Oct; 139(10):849-853. PubMed ID: 31430219
    [No Abstract]   [Full Text] [Related]  

  • 23. Acoustic analysis of voice in nonlaryngeal head and neck cancer patients post chemoradiotherapy.
    Radhakrishna N; Yamini BK; Kadam AS; Shivashankar N; Vishwanathan C; Javarappa R
    J Cancer Res Ther; 2017; 13(1):113-117. PubMed ID: 28508843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of the pretreatment geriatric nutritional risk index for predicting severe adverse events in patients with head and neck cancer treated with chemoradiotherapy.
    Nakayama M; Ohnishi K; Adachi M; Ii R; Matsumoto S; Nakamura M; Miyamoto H; Hirose Y; Nishimura B; Tanaka S; Wada T; Tabuchi K
    Auris Nasus Larynx; 2022 Apr; 49(2):279-285. PubMed ID: 34509306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nutritional surveillance in head and neck cancer patients during radiotherapy--the difference between concurrent chemoradiotherapy using high-dose cisplatin and radiotherapy alone].
    Nakahara S; Yoshino K; Fujii T; Uemura H; Suzuki M; Nishiyama K; Inohara H
    Nihon Jibiinkoka Gakkai Kaiho; 2012 Oct; 115(10):902-9. PubMed ID: 23214048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer: A multicenter retrospective analysis.
    Lee SY; Choi YS; Song IC; Park SG; Keam B; Yang YJ; Song EK; Lee HJ; Cho SH; Shim H; Park KU; Lee KH; Jo DY; Jo IS; Yun HJ;
    Medicine (Baltimore); 2018 May; 97(21):e10778. PubMed ID: 29794758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent chemoradiotherapy for head and neck cancers in older patients: Outcomes and their determinants.
    Srinivasalu VK; Subramaniam N; Balasubramanian D; Kumar N; Philip A; Susan A; Pushpaja KU; Nair AR; Thankappan K; Jose W; Iyer S; Keechilat P
    Indian J Cancer; 2019; 56(3):261-266. PubMed ID: 31389391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy.
    Nakano K; Sato Y; Toshiyasu T; Sato Y; Inagaki L; Tomomatsu J; Sasaki T; Shimbashi W; Fukushima H; Yonekawa H; Mitani H; Kawabata K; Takahashi S
    Mol Clin Oncol; 2016 Feb; 4(2):303-309. PubMed ID: 26893880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporation of Astragalus polysaccharides injection during concurrent chemoradiotherapy in advanced pharyngeal or laryngeal squamous cell carcinoma: preliminary experience of a phase II double-blind, randomized trial.
    Hsieh CH; Lin CY; Hsu CL; Fan KH; Huang SF; Liao CT; Lee LY; Ng SK; Yen TC; Chang JT; Lin JR; Wang HM
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):33-41. PubMed ID: 31728618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options.
    Iocca O; Farcomeni A; Di Rocco A; Di Maio P; Golusinski P; Pardiñas López S; Savo A; Pellini R; Spriano G
    Oral Oncol; 2018 May; 80():40-51. PubMed ID: 29706187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sonotubometric Assessment for Severity of Patulous Eustachian Tube.
    Takata I; Ikeda R; Kawase T; Suzuki Y; Sato T; Katori Y; Kobayashi T
    Otol Neurotol; 2017 Jul; 38(6):846-852. PubMed ID: 28437362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of Functional Nasal Voice in Patients With Patulous Eustachian Tube.
    Suzuki Y; Ikeda R; Hidaka H; Miyazaki H; Honkura Y; Sato T; Kawase T; Katori Y; Kobayashi T
    Otol Neurotol; 2018 Dec; 39(10):e1034-e1038. PubMed ID: 30239429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patulous Eustachian tube. Diagnostic evaluation by sonotubometry.
    Virtanen H
    Acta Otolaryngol; 1978; 86(5-6):401-7. PubMed ID: 716863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of middle ear immittance testing in the evaluation of patulous eustachian tube.
    McGrath AP; Michaelides EM
    J Am Acad Audiol; 2011 Apr; 22(4):201-7. PubMed ID: 21586254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
    Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M
    Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent Chemoradiotherapy With Weekly Low-Dose Cisplatin for Japanese Patients With Head and Neck Squamous Cell Carcinoma.
    Shinohara S; Takebayashi S; Hamaguchi K; Michida T; Tobe Y; Ikenaga T; Yasumoto M; Hamamoto A; Imagumbai T; Mitsuyoshi T; Ashida R; Iwai T; Okabayashi S
    Clin Med Insights Oncol; 2021; 15():11795549211048417. PubMed ID: 34629923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer.
    Chitapanarux I; Tharavichitkul E; Kamnerdsupaphon P; Pukanhapan N; Vongtama R
    J Radiat Res; 2013 Nov; 54(6):1110-7. PubMed ID: 23740894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligation of eustachian tube for intractable patulous eustachian tube: a preliminary report.
    Takano A; Takahashi H; Hatachi K; Yoshida H; Kaieda S; Adachi T; Takasaki K; Kumagami H; Tsukasaki N
    Eur Arch Otorhinolaryngol; 2007 Apr; 264(4):353-7. PubMed ID: 17061083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.
    Kimura H; Hamauchi S; Kawai S; Onozawa Y; Yasui H; Yamashita A; Ogawa H; Onoe T; Kamijo T; Iida Y; Onitsuka T; Yokota T
    Int J Clin Oncol; 2020 Feb; 25(2):258-266. PubMed ID: 31620932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of treatment and high-risk features in resectable locally advanced Head and Neck squamous cell carcinoma with special reference to extracapsular extension of nodal disease.
    Krstevska V
    J BUON; 2015; 20(4):943-53. PubMed ID: 26416042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.